Treatment response after palliative radiotherapy for bleeding gastric cancer: a multicenter prospective observational study (JROSG 17-3).
BACKGROUND
Palliative radiotherapy seems to be rarely performed for incurable gastric cancer. In this first multicenter study, we examined the effectiveness of palliative radiotherapy and investigated whether biologically effective dose (BED) is associated with survival, response, or re-bleeding.


METHODS
Eligibility criteria included blood transfusion or hemoglobin levels < 8.0 g/dL. The primary endpoint was the intention-to-treat (ITT) bleeding response rate at 4 weeks. Response entailed all of the following criteria: (i) hemoglobin levels ≥ 8.0 g/dL; (ii) 7 consecutive days without blood transfusion anytime between enrollment and blood sampling; and (iii) no salvage treatment (surgery, endoscopic treatment, transcatheter embolization, or re-irradiation) for bleeding gastric cancer. Re-bleeding was defined as the need for blood transfusion or salvage treatment.


RESULTS
We enrolled 55 patients from 15 institutions. The ITT response rates were 47%, 53%, and 49% at 2, 4, and 8 weeks, respectively. The per-protocol response rates were 56%, 78%, and 90% at 2, 4, and 8 weeks, respectively. Neither response nor BED (α/β = 10) predicted overall survival. Multivariable Fine-Gray model showed that BED was not a significant predictor of response. Univariable Cox model showed that BED was not significantly associated with re-bleeding. Grades 1, 2, 3, and, ≥ 4 radiation-related adverse events were reported in 11, 9, 1, and 0 patients, respectively.


CONCLUSIONS
The per-protocol response rate increased to 90% during the 8-week follow-up. The frequent occurrence of death starting shortly after enrollment lowered the ITT response rate. BED was not associated with survival, bleeding response, or re-bleeding.
['Saito|Tetsuo|T|http://orcid.org/0000-0003-1955-6773', 'Kosugi|Takashi|T|', 'Nakamura|Naoki|N|', 'Wada|Hitoshi|H|', 'Tonari|Ayako|A|', 'Ogawa|Hirofumi|H|', 'Mitsuhashi|Norio|N|', 'Yamada|Kazunari|K|', 'Takahashi|Takeo|T|', 'Ito|Kei|K|', 'Sekii|Shuhei|S|', 'Araki|Norio|N|', 'Nozaki|Miwako|M|', 'Heianna|Joichi|J|', 'Murotani|Kenta|K|', 'Hirano|Yasuhiro|Y|', 'Satoh|Atai|A|', 'Onoe|Tsuyoshi|T|', 'Watakabe|Takahiro|T|', 'Shikama|Naoto|N|']
Palliative radiotherapy Bleeding gastric cancer Multicenter prospective observational study Re-bleeding Response rate